Topic: diabetic retinopathy
Kodiak Sciences sold a capped 4.5% royalty on its eye disease drug that could rival Eylea in exchange for $225 million in development funding.
Darren Kelly, Ph.D., CEO of fibrosis-focused companies Certa Therapeutics and OccuRx, discusses his many jobs and the need for few fibrosis drugs.
Hillrom launched a new version of its handheld retinal camera under its Welch Allyn subsidiary, designed to spot the signs of diabetic retinopathy.
Shares in Aerpio Pharmaceuticals were more than halved in early trading this morning after it announced the failure of its leading drug candidate.
A collaboration between Unity Biotech and Ascentage Pharma has yielded a development candidate to treat age-related diseases of the eye.
Kodiak Sciences has filed to raise up to $100 million in its IPO to support the development of its anti-VEGF drug for eye diseases.
IDx developed the system, IDx-DR, to enable primary care clinics to assess whether patients with diabetes are at risk of vision loss.
Evotec will leverage its iPSC know-how with stem cell-based disease modeling to discover novel drugs for retinal diseases.
IBM developed a method combining deep learning and visual analytics to detect and gauge the severity of diabetic retinopathy from an eye image.